Choice of anesthetic combination determines Ca 2+ leak after ischemia-reperfusion injury in the working rat heart: Favorable versus adverse combinations

Anesthesiology

Volumn 116, Issue 3, 2012, Pages 648-657

  Zaugg, Michael ^a   Wang, Lianguo ^a   Zhang, Liyan ^a   Lou, Phing How ^a   Lucchinetti, Eliana ^a   Clanachan, Alexander S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; INDO 1; PHOSPHOLAMBAN; PROPOFOL; REACTIVE OXYGEN METABOLITE; REMIFENTANIL; RYANODINE RECEPTOR 2; SEVOFLURANE; TIOPRONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HEART LEFT VENTRICLE WORK; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM;

ANESTHETICS, COMBINED; ANIMALS; CALCIUM; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; PIPERIDINES; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862778862     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318247225a     Document Type: Article

References (32)

1. Symons JA, Myles PS: Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: A meta-analysis. Br J Anaesth 2006; 97:127-36 (Pubitemid 44295694)
2. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, Rodrigus IE: Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. ANESTHESIOLOGY 2002; 97:42-9 (Pubitemid 34733920)
3. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. ANESTHESIOLOGY 2003; 98:1315-27 (Pubitemid 36622462)
4. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, Cornu C, Lecharny JB, Aussage P, Vicaut E, Pons A, Lehot JJ: Sevoflurane preconditioning at 1MAC only provides limited protection in patients undergoing coronary artery bypass surgery: A randomized bi-centre trial. Br J Anaesth 2007; 99:624-31 (Pubitemid 351773223)
5. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW: ACC/AHA 2007 guidelines onperioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418-99
6. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. ANESTHESIOLOGY 2004; 100:707-21
7. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC: Anaesthetics and cardiac preconditioning. Part I: Signalling and cytoprotective mechanisms. Br J Anaesth 2003; 91: 551-65 (Pubitemid 37264906)
8. Halestrap AP, Clarke SJ, Javadov SA: Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004; 61: 372-85 (Pubitemid 38210145)
9. Zhang Y, Irwin MG, Wong TM, Chen M, Cao CM: Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. ANESTHESIOLOGY 2005; 102: 371-8 (Pubitemid 40189086)
10. Zaugg M: Is protection by inhalation agents volatile? Controversies in cardioprotection. Br J Anaesth 2007; 99:603-6
11. Zaugg M, Lucchinetti E, Garcia C, Pasch T, Spahn DR, Schaub MC: Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth 2003; 91:566-76 (Pubitemid 37258601)
12. Smul TM, Stumpner J, Blomeyer C, Lotz C, Redel A, Lange M, Roewer N, Kehl F: Propofol inhibits desflurane-induced preconditioning in rabbits. J Cardiothorac Vasc Anesth 2011; 25:276-81
13. Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, Warltier DC: Morphine enhances pharmacological preconditioning by isoflurane: Role of mitochondrial K(ATP) channels and opioid receptors. ANESTHESIOLOGY 2003; 98:705-11 (Pubitemid 36262598)
14. Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M: Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. ANESTHESIOLOGY 2010; 113:541-51
15. Lucchinetti E, Wang L, Ko KW, Troxler H, Hersberger M, Zhang L, Omar MA, Lopaschuk GD, Clanachan AS, Zaugg M: Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane-but not propofol-treated hearts. Br J Anaesth 2011; 106:792-800
16. Lamberts RR, Onderwater G, Hamdani N, Vreden MJ, Steenhuisen J, Eringa EC, Loer SA, Stienen GJ, Bouwman RA: Reactive oxygen species-induced stimulation of 5′AMP-activated protein kinase mediates sevoflurane-induced cardioprotection. Circulation 2009; 120:S10-5
17. Sedlic F, Pravdic D, Ljubkovic M, Marinovic J, Stadnicka A, Bosnjak ZJ: Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 2009; 109:405-11
18. Ogrodnik J, Niggli E: Increased Ca(2+) leak and spatiotemporal coherence of Ca(2+) release in cardiomyocytes during beta-adrenergic stimulation. J Physiol 2010; 588:225-42
19. van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL, Wang Q, De Almeida AC, Skapura DG, Anderson ME, Bers DM, Wehrens XH: Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010; 122:2669-79
20. Schaub MC, Hefti MA, Zaugg M: Integration of calcium with the signaling network in cardiac myocytes. J Mol Cell Cardiol 2006; 41:183-214 (Pubitemid 44080211)
21. Sossalla S, Fluschnik N, Schotola H, Ort KR, Neef S, Schulte T, Wittkpper K, Renner A, Schmitto JD, Gummert J, El-Armouche A, Hasenfuss G, Maier LS: Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res 2010; 107: 1150-61
22. Currie S, Smith GL: Calcium/calmodulin-dependent protein kinase IIactivity is increased in sarcoplasmic reticulum from coronary artery ligated rabbit hearts. FEBS Lett 1999; 459: 244-8 (Pubitemid 29475040)
23. Toko H, Takahashi H, Kayama Y, Oka T, Minamino T, Okada S, Morimoto S, Zhan DY, Terasaki F, Anderson ME, Inoue M, Yao A, Nagai R, Kitaura Y, Sasaguri T, Komuro I: Ca2+/calmodulin-dependent kinase II delta causes heart failure by accumulation of p53 in dilated cardiomyopathy. Circulation 2010; 122:891-9
24. Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP: Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 2007; 282:10833-9 (Pubitemid 47093465)
25. Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM: Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: Reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res 2003; 92:904-11 (Pubitemid 36542532)
26. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, Price EE Jr, Thiel W, Guatimosim S, Song LS, Madu EC, Shah AN, Vishnivetskaya TA, Atkinson JB, Gurevich VV, Salama G, Lederer WJ, Colbran RJ, Anderson ME: Calmodulin kinase IIinhibition protects against structural heart disease. Nat Med 2005; 11:409-17 (Pubitemid 40562331)
27. Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE, Abdellatif M, Feldman DS, Elton TS, Gyrke S: miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res 2009; 104:514-21
28. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Garcia C, Schaub MC: Differential effects of anesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. ANESTHESIOLOGY 2002; 97:15-23 (Pubitemid 34733917)
29. Zhao M, Joo DT: Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. ANESTHESIOLOGY 2008; 109:308-17
30. Zhang Y, Irwin MG, Li R, Chen ZW, Wong TM: Effects of remifentanil on intracellular Ca(2+) and its transients induced by electrical stimulation and caffeine in rat ventricular myocytes. Chin Med J (Engl) 2009; 122:1439-43
31. Grkan A, Birgl Y, Ziya K: Direct cardiac effects in isolated perfused rat hearts of fentanyl and remifentanil. Ann Card Anaesth 2005; 8:140-4
32. Weihrauch D, Krolikowski JG, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS: Morphine enhances isoflurane-induced postconditioning against myocardial infarction: The role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 2005; 101:942-9 (Pubitemid 41383051)